InvestorsHub Logo
Followers 32
Posts 3333
Boards Moderated 0
Alias Born 08/31/2006

Re: fraum post# 95253

Thursday, 06/20/2019 12:50:08 AM

Thursday, June 20, 2019 12:50:08 AM

Post# of 144817
TD2 learned a lot if not everything about this technology

"...which TD2 will conduct preclinical and clinical studies in support of the development of Nuvilex's pancreatic cancer and other treatments utilizing Cell-in-a-Box® technology.

"The Nuvilex team presents us with a new tool to employ against the symptoms and invasive properties of this very challenging cancer," said Daniel D. Von Hoff,...."

April 01, 2014

https://www.globenewswire.com/news-release/2014/04/01/623377/10074859/en/Nuvilex-Selects-Translational-Drug-Development-TD2-to-Advance-Treatment-for-Pancreatic-Cancer.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News